EBS

Emergent Biosolutions Stock Price

66.90
1.68 (2.58%)
Upgrade to Real-Time
Afterhours (Closed)
66.90

Low
55.0692

52 Week Range

High
137.61

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Emergent Biosolutions Inc EBS NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
1.68 2.58% 66.90 20:00:00
Open Price Low Price High Price Close Price Prev Close
60.61 60.50 67.69 65.90 65.22
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12,356 887,926 $ 65.60 $ 58,251,647 - 55.0692 - 137.61
Last Trade Time Type Quantity Stock Price Currency
19:47:50 47 $ 66.89 USD

Period:

Draw Mode:

Emergent Biosolutions Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.58B 53.59M 43.18M $ 1.56B $ 349.50M 5.66 9.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 27.32k 3.90%

more financials information »

Emergent Biosolutions News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EBS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week64.3968.028160.5064.34379,0832.513.9%
1 Month64.0068.028157.8262.62464,7592.904.53%
3 Months61.4168.028155.069261.66647,7535.498.94%
6 Months108.00127.2055.069275.00740,941-41.10-38.06%
1 Year93.08137.6155.069288.07680,378-26.18-28.13%
3 Years53.69137.6139.1173.47530,30913.2124.6%
5 Years31.92137.6124.4763.32444,46634.98109.59%

Emergent Biosolutions Description

Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products.
Your Recent History
NYSE
EBS
Emergent B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210801 16:26:44